Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08815_nanopub.RAigKA78_IHSWka677f_2oiwD0zM6xEQodQwW49yBHtlw#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB08815 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08815 label "Lurasidone [drugbank:DB08815]" assertion.
- drugbank:DB08815 seeAlso DB08815 assertion.
- drugbank:DB08815 seeAlso lurasidone.html assertion.
- drugbank:DB08815 seeAlso latuda-drug.htm assertion.
- drugbank:DB08815 identifier "drugbank:DB08815" assertion.
- drugbank:DB08815 description "Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States. (Wikipedia)" assertion.
- drugbank:DB08815 title "Lurasidone" assertion.
- drugbank:DB08815 bio2rdf_vocabulary:identifier "DB08815" assertion.
- drugbank:DB08815 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08815 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08815" assertion.
- drugbank:DB08815 bio2rdf_vocabulary:x-identifiers.org DB08815 assertion.
- drugbank:DB08815 drugbank_vocabulary:drugbank-id "DB08815" assertion.
- drugbank:DB08815 drugbank_vocabulary:x-cas cas:367514-87-2 assertion.
- drugbank:DB08815 drugbank_vocabulary:x-ahfs ahfs:28:16.08.04 assertion.
- drugbank:DB08815 drugbank_vocabulary:x-atc atc:N05AE05 assertion.
- drugbank:DB08815 drugbank_vocabulary:x-chebi chebi:70735 assertion.
- drugbank:DB08815 drugbank_vocabulary:x-kegg kegg:D04820 assertion.
- drugbank:DB08815 drugbank_vocabulary:x-wikipedia wikipedia:Lurasidone assertion.
- drugbank:DB08815 drugbank_vocabulary:x-ndc ndc:63402-312-30 assertion.